vs

Side-by-side financial comparison of Organon & Co. (OGN) and XPO, Inc. (XPO). Click either name above to swap in a different company.

XPO, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× Organon & Co.). XPO, Inc. runs the higher net margin — 4.8% vs -13.6%, a 18.4% gap on every dollar of revenue. On growth, XPO, Inc. posted the faster year-over-year revenue change (7.3% vs -5.3%). Over the past eight quarters, XPO, Inc.'s revenue compounded faster (0.4% CAGR vs -3.6%).

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

XPO, Inc., formerly XPO Logistics, is an American transportation company that conducts less-than-truckload shipping in North America. The company has headquarters in Greenwich, Connecticut, and has 592 locations globally. XPO is the second largest provider of less-than-truckload (LTL) services in North America, operating in 99 percent of all U.S. postal codes.

OGN vs XPO — Head-to-Head

Bigger by revenue
XPO
XPO
1.4× larger
XPO
$2.1B
$1.5B
OGN
Growing faster (revenue YoY)
XPO
XPO
+12.6% gap
XPO
7.3%
-5.3%
OGN
Higher net margin
XPO
XPO
18.4% more per $
XPO
4.8%
-13.6%
OGN
Faster 2-yr revenue CAGR
XPO
XPO
Annualised
XPO
0.4%
-3.6%
OGN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OGN
OGN
XPO
XPO
Revenue
$1.5B
$2.1B
Net Profit
$-205.0M
$101.0M
Gross Margin
49.2%
Operating Margin
-9.8%
8.3%
Net Margin
-13.6%
4.8%
Revenue YoY
-5.3%
7.3%
Net Profit YoY
-288.1%
46.4%
EPS (diluted)
$-0.78
$0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OGN
OGN
XPO
XPO
Q1 26
$2.1B
Q4 25
$1.5B
$2.0B
Q3 25
$1.6B
$2.1B
Q2 25
$1.6B
$2.1B
Q1 25
$1.5B
$2.0B
Q4 24
$1.6B
$1.9B
Q3 24
$1.6B
$2.1B
Q2 24
$1.6B
$2.1B
Net Profit
OGN
OGN
XPO
XPO
Q1 26
$101.0M
Q4 25
$-205.0M
$59.0M
Q3 25
$160.0M
$82.0M
Q2 25
$145.0M
$106.0M
Q1 25
$87.0M
$69.0M
Q4 24
$109.0M
$75.0M
Q3 24
$359.0M
$95.0M
Q2 24
$195.0M
$150.0M
Gross Margin
OGN
OGN
XPO
XPO
Q1 26
Q4 25
49.2%
Q3 25
53.5%
Q2 25
54.8%
Q1 25
55.6%
Q4 24
56.3%
Q3 24
58.3%
Q2 24
58.4%
Operating Margin
OGN
OGN
XPO
XPO
Q1 26
8.3%
Q4 25
-9.8%
7.1%
Q3 25
15.2%
7.8%
Q2 25
14.4%
9.5%
Q1 25
6.7%
7.7%
Q4 24
8.1%
7.8%
Q3 24
13.1%
8.6%
Q2 24
14.6%
9.5%
Net Margin
OGN
OGN
XPO
XPO
Q1 26
4.8%
Q4 25
-13.6%
2.9%
Q3 25
10.0%
3.9%
Q2 25
9.1%
5.1%
Q1 25
5.8%
3.5%
Q4 24
6.8%
3.9%
Q3 24
22.7%
4.6%
Q2 24
12.1%
7.2%
EPS (diluted)
OGN
OGN
XPO
XPO
Q1 26
$0.85
Q4 25
$-0.78
$0.49
Q3 25
$0.61
$0.68
Q2 25
$0.56
$0.89
Q1 25
$0.33
$0.58
Q4 24
$0.42
$0.63
Q3 24
$1.38
$0.79
Q2 24
$0.75
$1.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OGN
OGN
XPO
XPO
Cash + ST InvestmentsLiquidity on hand
$574.0M
$237.0M
Total DebtLower is stronger
$8.6B
$3.3B
Stockholders' EquityBook value
$752.0M
$1.9B
Total Assets
$12.9B
$8.2B
Debt / EquityLower = less leverage
11.49×
1.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OGN
OGN
XPO
XPO
Q1 26
$237.0M
Q4 25
$574.0M
$310.0M
Q3 25
$672.0M
$335.0M
Q2 25
$599.0M
$225.0M
Q1 25
$547.0M
$212.0M
Q4 24
$675.0M
$246.0M
Q3 24
$763.0M
$378.0M
Q2 24
$704.0M
$250.0M
Total Debt
OGN
OGN
XPO
XPO
Q1 26
$3.3B
Q4 25
$8.6B
Q3 25
$8.8B
Q2 25
$8.9B
Q1 25
$9.0B
Q4 24
$8.9B
Q3 24
$8.7B
Q2 24
$8.7B
Stockholders' Equity
OGN
OGN
XPO
XPO
Q1 26
$1.9B
Q4 25
$752.0M
$1.9B
Q3 25
$906.0M
$1.8B
Q2 25
$733.0M
$1.8B
Q1 25
$542.0M
$1.6B
Q4 24
$472.0M
$1.6B
Q3 24
$493.0M
$1.6B
Q2 24
$144.0M
$1.5B
Total Assets
OGN
OGN
XPO
XPO
Q1 26
$8.2B
Q4 25
$12.9B
$8.2B
Q3 25
$13.6B
$8.2B
Q2 25
$13.5B
$8.1B
Q1 25
$13.2B
$7.9B
Q4 24
$13.1B
$7.7B
Q3 24
$12.8B
$7.9B
Q2 24
$12.2B
$7.7B
Debt / Equity
OGN
OGN
XPO
XPO
Q1 26
1.77×
Q4 25
11.49×
Q3 25
9.74×
Q2 25
12.14×
Q1 25
16.52×
Q4 24
18.81×
Q3 24
17.75×
Q2 24
60.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OGN
OGN
XPO
XPO
Operating Cash FlowLast quarter
$141.0M
$183.0M
Free Cash FlowOCF − Capex
$96.0M
FCF MarginFCF / Revenue
6.4%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
1.81×
TTM Free Cash FlowTrailing 4 quarters
$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OGN
OGN
XPO
XPO
Q1 26
$183.0M
Q4 25
$141.0M
Q3 25
$264.0M
$371.0M
Q2 25
$220.0M
$247.0M
Q1 25
$75.0M
$142.0M
Q4 24
$390.0M
$189.0M
Q3 24
$141.0M
$264.0M
Q2 24
$332.0M
$210.0M
Free Cash Flow
OGN
OGN
XPO
XPO
Q1 26
Q4 25
$96.0M
Q3 25
$218.0M
$215.0M
Q2 25
$181.0M
$51.0M
Q1 25
$43.0M
$-57.0M
Q4 24
$335.0M
$23.0M
Q3 24
$99.0M
$137.0M
Q2 24
$300.0M
$20.0M
FCF Margin
OGN
OGN
XPO
XPO
Q1 26
Q4 25
6.4%
Q3 25
13.6%
10.2%
Q2 25
11.4%
2.5%
Q1 25
2.8%
-2.9%
Q4 24
21.0%
1.2%
Q3 24
6.3%
6.7%
Q2 24
18.7%
1.0%
Capex Intensity
OGN
OGN
XPO
XPO
Q1 26
Q4 25
3.0%
5.3%
Q3 25
2.9%
7.4%
Q2 25
2.4%
9.4%
Q1 25
2.1%
10.2%
Q4 24
3.5%
8.6%
Q3 24
2.7%
6.2%
Q2 24
2.0%
9.1%
Cash Conversion
OGN
OGN
XPO
XPO
Q1 26
1.81×
Q4 25
Q3 25
1.65×
4.52×
Q2 25
1.52×
2.33×
Q1 25
0.86×
2.06×
Q4 24
3.58×
2.52×
Q3 24
0.39×
2.78×
Q2 24
1.70×
1.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons